IBLA 2023 19th Edition: Kiran Mazumdar-Shaw awarded Outstanding Business Leader of the Year

Biocon’s Kiran Mazumdar-Shaw was honoured as the Outstanding Business Leader of the Year at the 19th edition of CNBC-TV18's India Business Leader Awards (IBLA), held in Mumbai on December 2.

In business, as in everything else, leadership extends beyond profit margins. It's about transforming lives. Kiran Mazumdar-Shaw lives and breathes that mission every day.

An exceptional biotech entrepreneur, healthcare visionary and global influencer, she has nurtured and led Biocon from a small startup into a globally renowned and respected business with a footprint that covers over 100 countries.

Biocon is today India's largest global Biosimilars Company, with revenues in excess of $1.4 billion and total assets worth over $6.5 billion. It has positively impacted 5.7 million lives by making life-saving therapies more accessible and affordable and innovating to increase treatment options.

Kiran Mazumdar-Shaw has spearheaded Biocon through crucial breakthroughs – it created the world's first biosimilar Trastuzumab to treat breast cancer and is the first company in the world to commercialise a synthetic version of human insulin to battle diabetes.

Her four-decade long entrepreneurial journey has led her to not one, but two of India’s highest civilian honours: the Padma Shri, and the Padma Bhushan.

But Kiran Mazumdar-Shaw's legacy goes beyond the lab and the boardroom -- She is the first woman business leader from India to sign the Giving Pledge, and set aside a major portion of her wealth to assist transformative causes.

CNBC-TV18 celebrates Kiran Mazumdar-Shaw —a true pioneer, visionary leader, and inspiration.